Dáil Éireann Debate, Wednesday - 4 May 2005
201 Mr. Kenny asked the Tánaiste and Minister for Health and Children her views on the recommendation of the European Medicines Agency that two classes of antidepressants should not be used in children and adolescents except in their approved indications; and if she will make a statement on the matter. [14354/05]
Amharc ar fhreagraAs the competent authority for the regulation of medicinal products in Ireland, the Irish Medicines Board assesses the safety, quality and efficacy of medicinal products. The matter raised by the Deputy is one which falls within the IMB's remit.
The use of antidepressants in children and adolescents has been the subject of continuous review at both national and EU level for some time and the IMB has actively participated in this review. With regard to the classes of antidepressants referred to by the Deputy, the board is aware of the recommendation of the European Medicines Agency and supports it. These products are not licensed for use in the treatment of depression in children in Ireland. Doctors can prescribe these products for individual patients if they feel they may be of benefit but they are advised to exercise caution. Alternative treatments for childhood depression, such as cognitive behavioural therapy, may be prescribed by child psychiatrists.
202 Mr. Kenny asked the Tánaiste and Minister for Health and Children the number of persons under 18 years of age being prescribed antidepressants on the medical card scheme; and if she will make a statement on the matter. [14355/05]
Amharc ar fhreagraThe number of medical card holders under 18 years for whom antidepressants were prescribed in 2004 was 2,541.
